About HealthLinx
HealthLinx uses biomarkers to develop best practice diagnostics that detect and monitor diseases. First commercial targets are: ovarian cancer diagnostic (OvPlex) targeting US$250m pa market; and pregnancy diagnostic. This would be used in a woman’s first prenatal visit to identify whether she is at high risk of having complications during pregnancy. Currently there is no product on the market which identifies complications in early stages of pregnancy.
Facts about HealthLinx
Facts about HealthLinx
- Focus : Manufacturer
- Industry : Diagnostics
